Related Experiment Videos
Current managements and outcomes of peptic and artificial ulcer bleeding in Japan
Mitsuhiro Fujishiro1, Nobutsugu Abe, Masaki Endo
1Department of Endoscopy and Endoscopic Surgery, The University of Tokyo, Tokyo, Japan. mtfujish-kkr@umin.ac.jp
Insights
This study shows endoscopic treatments for peptic and artificial ulcer bleeding in Japan are highly effective, with similar excellent outcomes. Management strategies for these gastroduodenal ulcers varied slightly but resulted in successful hemostasis and low rebleeding rates.
Area of Science:
- Gastroenterology
- Endoscopy
- Internal Medicine
Background:
- Gastroduodenal ulcer bleeding trends in Japan, particularly artificial ulcers, require detailed elucidation.
- Current management and outcomes for peptic and artificial ulcer bleeding are not well-defined.
Purpose of the Study:
- To investigate current management strategies and outcomes for peptic and artificial ulcer bleeding in Japan.
- To compare the efficacy of endoscopic treatments for these two types of gastroduodenal ulcers.
Main Methods:
- A retrospective, multicenter study of 325 patients with nonmalignant gastroduodenal ulcer bleeding.
- Data collected included hemostasis success rates, rebleeding, surgical intervention, death, endoscopic methods, and second-look endoscopy timing.
- Patients were treated between January 2008 and December 2008 at nine high-volume Japanese hospitals.
Main Results:
- Successful initial hemostasis was achieved in 99.1% of peptic ulcer patients and 100% of artificial ulcer patients.
- Rebleeding rates were 10.1% for peptic ulcers and 11.9% for artificial ulcers.
- No deaths were observed; surgical rescue was required in only a few cases. Differences noted in endoscopic methods and second-look endoscopy frequency.
Conclusions:
- Endoscopic treatment for nonmalignant gastroduodenal bleeding in Japan yields excellent outcomes for both peptic and artificial ulcers.
- While overall efficacies are similar, minor variations exist in endoscopic techniques, medication use, and the application of second-look endoscopy.
- The study highlights the effectiveness of current endoscopic interventions for gastroduodenal bleeding in Japan.
Abstract:
The recent trend of gastroduodenal ulcer bleeding in Japan has not been elucidated in detail and the data for a new categorized type, artificial ulcer bleeding, is completely lacking. The purpose of this paper is to elucidate current managements and outcomes of peptic and artificial ulcer bleeding in Japan. A retrospective multicenter study of consecutive case series was carried out during one year at nine departments of high-volume hospitals in Japan. The study included 325 consecutive patients (239 with peptic ulcers and 86 with artificial ulcers) with bleeding nonmalignant gastroduodenal ulcers that were revealed by emergency endoscopy between January 2008 and December 2008. Hemostasis was carried out mainly using endoscopic treatments. Rates of successful initial hemostasis, rebleeding, transfer to surgery, and death were recorded according to peptic and artificial ulcer bleeding. Additionally, preferred endoscopic methods, concomitant use of antisecretory drugs, and timing of second-look endoscopy were also measured. A total of 227 (99.1%) of 229 peptic ulcer patients with endoscopic treatment and all (100%) 84 artificial ulcer patients underwent successful tentative hemostasis. Rebleeding occurred in 23 peptic ulcer patients (10.1%) and 10 artificial ulcer patients (11.9%). One peptic ulcer patient and two artificial ulcer patients had final surgical rescue due to rebleeding. No death was observed. Monotherapy was predominant (around 65% of cases) in both types of ulcers. The coagulation forceps method was more frequently applied in artificial ulcers (P < 0.05). A per oral proton pump inhibitor was more frequently used in artificial ulcers (P < 0.05), although an intravenous proton pump inhibitor was used in the majority of patients in both types of ulcers. The frequency of second-look endoscopy in peptic ulcers (88%) was significantly higher than that in artificial ulcers (71%) (P < 0.05). There seemed to be no rule as to the timing of second-look endoscopy, although it was most frequently performed on the day after hemostasis. The recent outcomes of endoscopic treatment for nonmalignant gastroduodenal bleeding in Japan were excellent in both peptic and artificial ulcers with similar efficacies. Although they were minor findings, some differences in applied endoscopic methods, concomitant use of antisecretory drugs, and presence of second-look endoscopy were observed.
Related Concept Videos
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...